Literature DB >> 17364842

Prevalence of illicit drug use in Asia and the Pacific.

Madonna L Devaney1, Gary Reid, Simon Baldwin.   

Abstract

This paper reports on the prevalence of drug use in Asia and the Pacific. It is based on the report "Situational analysis of illicit drug issues and responses in Asia and the Pacific", commissioned by the Australian National Council on Drugs Asia Pacific Drug Issues Committee. Review of existing estimates of the prevalence of people who use illicit drugs from published and unpublished literature and information from key informants and regional institutions was undertaken for the period 1998 - 2004. Estimates of the prevalence of people who use illicit drugs were conducted for 12 Asian and six Pacific Island countries. The estimated prevalence of those using illicit drugs ranges from less than 0.01% to 4.6%. Countries with estimated prevalence rates higher than 2% are Cambodia, Hong Kong, Philippines, Thailand, Indonesia, Laos and Malaysia. China, Myanmar and Vietnam have estimated prevalence rates ranging between less than 0.01% and 2%. Data to estimate prevalence rates was not available for Pacific Island countries and Brunei. Estimates of the prevalence of drug use are critical to policy development, planning responses and measuring the coverage of programs. However, reliable estimates of the numbers of people using illicit drugs are rare in Asia, particularly the Pacific.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17364842     DOI: 10.1080/09595230601037034

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  7 in total

1.  Thizzin'-Ecstasy use contexts and emergent social meanings.

Authors:  Juliet P Lee; Robynn S Battle; Brian Soller; Naomi Brandes
Journal:  Addict Res Theory       Date:  2011

2.  Development of mental healthcare in Cambodia: barriers and opportunities.

Authors:  Sarah J Parry; Nil Ean; Shirley P Sinclair; Ewan Wilkinson
Journal:  Int J Ment Health Syst       Date:  2020-07-29

3.  Defining and redefining harm reduction in the Lao context.

Authors:  Vanphanom Sychareun; Visanou Hansana; Sysavanh Phommachanh; Vathsana Somphet; Phouthong Phommavongsa; Brigitte Tenni; Timothy Moore; Nick Crofts
Journal:  Harm Reduct J       Date:  2012-07-09

4.  Cytogenetic risks and possible adverse health effects by narcotic substances dependent.

Authors:  Abolfazl Movafagh; Ali Haeri; Ali Asghar Kolahi; Hossein Hassani-Moghadam
Journal:  Int J Prev Med       Date:  2012-09

5.  Harm reduction and "clean" community: can Viet Nam have both?

Authors:  Thu Hong Khuat; Van Anh Thi Nguyen; Melissa Jardine; Timothy Moore; Thu Huong Bui; Nick Crofts
Journal:  Harm Reduct J       Date:  2012-07-09

6.  A cross-national comparison of violence among young men in China and the UK: psychiatric and cultural explanations.

Authors:  Jeremy Coid; Junmei Hu; Constantinos Kallis; Yuan Ping; Juying Zhang; Yueying Hu; Laura Bui; Simone Ullrich; Paul Bebbington
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-08-11       Impact factor: 4.328

7.  Methamphetamine-type stimulant use in Lao PDR: qualitative findings from users aged 15-25 years in Vientiane Capital and Vientiane Province.

Authors:  Vanphanom Sychareun; Bangone Santavasy; Niramonh Chanlivong; Andrea Fischer; Nicholas Thomson; Robert Power; Jo Durham
Journal:  Harm Reduct J       Date:  2018-04-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.